Literature DB >> 18494268

[Frequency and characteristics of metabolic disorders in patients on haemodialysis].

Radojica Stolić1, Goran Trajković, Vladan Perić, Aleksandar Jovanović, Dragica Stolić, Sasa Sovtić, Gordana Subarić-Gorgieva.   

Abstract

BACKGROUND/AIM: . Metabolic syndrome and malnutrition represent metabolic abnormalities which significantly characterize patients on haemodialysis. The aim of the study was to determine the incidence and find characteristics of metabolic disbalance in patients on haemodialysis.
METHODS: The study involved 124 patients on chronic haemodialysis at the Clinical Centre Kragujevac. There were analyzed demographic and anthropometric characteristics of the examined patients. Of clinical characteristics, there were determined smoking habit, time on dialysis, arterial pressure; of comorbid states there were recorded heart diseases and diabetes mellitus. Routine biochemical analyses were carried out by a standard laboratory procedure.
RESULTS: Metabolic syndrome was found in 29.8% of the examined patients. The patients with metabolic syndrome were older as compared to the patients without metabolic syndrome (58.45 +/- 12.91 vs 52.25 +/- 11.63 years). The values of systolic pressure (143.88 +/- 19.75 vs 133.01 +/- 22.93 mmHg; p = 0.014), body mass index (21.2 +/- 3.71 vs 19.4 +/- 2.88 kg/m2;p = 0.001), fat body mass (19.57 +/- 8.47 vs 16.45 +/- 5.82%; p = 0.0002) and waist scope (89 +/- 12.54 vs 96 +/- 12.34 cm; p = 0.0001) were significantly higher in the patients with metabolic syndrome as compared to those without metabolic syndrome. The values of erythrocytes (3.4 +/- 0.45 vs 19 +/- 0.53 x 10(12); p = 0.04) and hemoglobin (107 +/- 15.76 vs 101 +/- 13.87 g/l; p = 0.009), glycaemia (9.5 +/- 8.15 vs 5.6 +/- 1.4 mmol/l; p = 0.04) triglycerides (2.44 +/- 1.8 vs 1.41 +/- 0.64 mmol/l; p = 0.007), HDL cholesterol (1.11 +/- 0.19 vs 0.82 +/- 0.25 mmol/l; p = 0.005) and albumins (32.5 +/- 5.6 vs 29.5 +/- 3.7 g/l; p = 0.007) were statistically higher in the patients with metabolic syndrome than in patients without disturbance. Diabetes mellitus was a significant etiological factor of renal insufficiency in the patients with metabolic syndrome (p = 0.008).
CONCLUSION: In our study approximately 30% of patients on haemodialysis had pronounced metabolic syndrome. The older, more obese men with increased levels of triglycerides and glucose in the serum dominated among them. Diabetes mellitus was a leading etiological factor of renal insufficiency in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18494268     DOI: 10.2298/vsp0803205s

Source DB:  PubMed          Journal:  Vojnosanit Pregl        ISSN: 0042-8450            Impact factor:   0.168


  5 in total

1.  Nutrition parameters as hemodialysis adequacy markers.

Authors:  R Stolic; G Trajkovic; D Stolic; V Peric; G Subaric-Gorgieva
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

2.  Association between metabolic syndrome and coronary heart disease in patients on hemodialysis.

Authors:  Mojgan Jalalzadeh; Nouraddin Mousavinasab; Mehrdad Soloki; Reza Miri; Mohammad Hassan Ghadiani; Maryam Hadizadeh
Journal:  Nephrourol Mon       Date:  2015-01-20

3.  Age related metabolic syndrome among hemodialysis patients in gorgan, iran.

Authors:  Abdoljalal Marjani; Mohammad Moujerloo; Sharabeh Hezarkhani
Journal:  Open Biochem J       Date:  2013-02-08

4.  Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study.

Authors:  Josep Bonet; Albert Martinez-Castelao; Beatriz Bayés
Journal:  Diabetes Metab Syndr Obes       Date:  2013-09-18       Impact factor: 3.168

5.  Associations of Cardiovascular and All-Cause Mortality with Metabolic Syndrome in Hemodialysis Patients: A Prospective Single-Center Study.

Authors:  Zorica Dimitrijevic; Andriana Jovanovic; Mina Cvetkovic; Tamara Vrecic; Emina Kostic; Branka Mitic
Journal:  Medicina (Kaunas)       Date:  2019-10-16       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.